Treating coronary heart disease in kidney failure patientsNovember 29th, 2012 in Diseases, Conditions, Syndromes /
Among the two available procedures for opening blocked arteries surrounding the heart, one appears to be safer than the other for dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may help lead to better care for kidney failure patients with coronary heart disease.
While 30% to 60% of kidney failure patients on dialysis have blocked arteries surrounding the heart, there is little information regarding how to optimally fix the life-threatening problem in these individuals. That's because dialysis patients have been excluded from clinical trials on the two available procedures: open heart surgery (coronary artery bypass grafting, or CABG) and angioplasty (percutaneous coronary intervention, or PCI).
Tara Chang, MD, Wolfgang Winkelmayer, MD, ScD (Stanford University School of Medicine) and their colleagues examined a database of all patients on dialysis in the United States with primary Medicare coverage to determine which is the best revascularization strategy: CABG or PCI. They identified nearly 22,000 dialysis patients who underwent CABG or PCI between 1997 and 2009.
Among the major findings:
- Overall survival rates were poor, with five-year survival rates of 22% to 25% irrespective of revascularization strategy. (Five-year survival rates in patients without kidney disease are over 90%.)
- CABG was associated with a 13% lower risk of death and a 12% lower risk of either dying or having a heart attack.
More information: The article, entitled "Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD," will appear online at jasn.asnjournals.org/ on November 29, 2012.
Provided by American Society of Nephrology
"Treating coronary heart disease in kidney failure patients." November 29th, 2012. http://medicalxpress.com/news/2012-11-coronary-heart-disease-kidney-failure.html